Skip to main content

Table 1 Antibodies used in the present study.

From: Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization

Antibody

Type

Source

Dilution

Vimentin

M

Dakopatts, Kyoto, Japan

1:50

EMA

M

Dakopatts

1:50

AE1/AE3

M

Dakopatts

1:50

CAM 5.2

M

Becton Dickinson, San Jose, CA, USA

1:50

Desmin

M

Dakopatts

1:50

α-SMA

M

Dakopatts

1:50

MSA (HHF35)

M

Enzo Diagnostics, Farmingdale, NY, USA

1:50

S-100 protein

P

Dakopatts

1:1000

NSE

M

Dakopatts

1:200

CD68 (KP-1)

M

Dakopatts

1:200

Lysozyme

P

Dakopatts

1:500

AAT

P

Dakopatts

1:1000

ACT

P

Dakopatts

1:1000

C-Kit

P

Immuno-Biological Laboratories, Fujioka, Japan

1:10

  1. Abbreviations: EMA, epithelial membrane antigen; α-SMA, alpha-smooth muscle actin; MSA, muscle-specific actin; NSE, neuron-specific enolase; AAT, alpha-1-antitrypsin; ACT, alpha-1-antichymotrypsin; M, monoclonal (mouse); P, polyclonal (rabbit).